Hospital Wide

Maximum efficiency and availability throughout the hospital

Issues in bleeding and thrombosis are shared across nearly all hospital specialty areas, from bariatrics to orthopedics. Consistent use of TEG®-guided hemostasis and blood management protocols can reduce risks associated with both bleeding and thrombosis...reducing both blood product usage and all the undesirable and life-threatening complications associated with blood product transfusions. Identifying a prothrombotic state and treating appropriately can reduce the risks and consequences of ischemic events. TEG® analysis can help risk stratify a patient's prothrombotic state and guide and monitor therapy, including personalizing use of various therapies, including anticoagulants and antiplatelet drugs.

The TEG® 5000 Haemostasis System is suited for both central laboratory and point of care use. Point-of-care use provides immediate results at the patient's bedside, as might be appropriate in critical surgical situations such as cardiovascular or liver surgery.

Whole blood samples can be sent for analysis in the central laboratory and results reported in real time via remote workstations located anywhere on the hospital network. Under the leadership of a pathologist/hematologist, the laboratory setting provides a centralized point for sample analysis and interpretation. This maximizes efficiency and availability of hemostasis information throughout the hospital.